Neurol Ther March 2022 PMID 34727345

Use of a Novel EEG-Based Objective Test, the Cognalyzer, in Quantifying the Strength and Determining the Action Time of Cannabis Psychoactive Effects and Factors that May Influence Them Within an Observational Study Framework.

Dan Bosnyak, Alison C McDonald, Israel Gasperin Haaz, Weikai Qi, David C Crowley, Najla Guthrie, Malkanthi Evans

Download social card

Mentions

8
Peak: 3 in Mar 2025
across 3 sources since Nov 2021

Extended reach

2,029
potential audience

Total likes

34

Video views

921

Mentions per month

Nov 2021 – Mar 2025

Where it's discussed

  • YouTube3 videos
  • News3 articles
  • X / Twitter2 posts

AI synopsis

What people are saying

The posts highlight the study's focus on measurable cannabis effects through the Cognalyzer, with phrases like 'assessed the relationship' and 'read the findings here' indicating interest and support. The tone is informative rather than argumentative, reflecting a curious yet reserved engagement that recognizes the potential impact of this EEG-based testing method.

AgreementModerate agreement

The discussion indicates general agreement with the study's findings, emphasizing its relevance and potential significance.

InterestModerate interest

The posts show moderate interest, focusing on the study's importance and offering links to read further.

EngagementNeutral engagement

Engagement appears cautious, mainly limited to sharing summaries and encouraging reading without deep analysis.

ImpactModerate impact

The study seems to be viewed as a noteworthy development, potentially influencing future research or methods in the field.

Abstract in brief

  • The study introduces the Cognalyzer, a new EEG-based test that measures the strength and timing of cannabis's psychoactive effects, which traditional methods can't do objectively.
  • Researchers found that the Cognalyzer's predictions correlated significantly with participants' self-reported drug effects, and its readings varied based on factors like cannabis use history and THC levels.
  • Overall, the findings suggest the Cognalyzer can effectively quantify how strong cannabis's effects are on individuals and how these effects change over time.]

Top posts

Most liked on X and Bluesky
Neurology and Therapy
@Neurology_Ther · X

This study assessed the relationship between the magnitude of #Cognalyzer® #psychoactive effects predictions and reported subjective drug effects for 4 h post-#cannabis inhalation. Read the findings here: https://t.co/OXKXfm67w3 https://t.co/jFVOOqkGUJ

Nov 2, 2021 · 3 likes · 1 share · 958 followers View post →
The Richard Rose Report
@TheRRreport · X

PubMed: Use of a Novel EEG-Based Objective Test, the Cognalyzer(), in Quantifying the Strength and Determining the Action Time of Cannabis Psychoactive Effects and Factors that May Influence Them Within an Observational Study Framework https://t.co/tZNw50mZOa #hemp #CBD ...

Nov 3, 2021 · 148 followers View post →

All mentions

The Richard Rose Report
@TheRRreport · X

PubMed: Use of a Novel EEG-Based Objective Test, the Cognalyzer(), in Quantifying the Strength and Determining the Action Time of Cannabis Psychoactive Effects and Factors that May Influence Them Within an Observational Study Framework https://t.co/tZNw50mZOa #hemp #CBD ...

Nov 3, 2021 · 148 followers View post →
Neurology and Therapy
@Neurology_Ther · X

This study assessed the relationship between the magnitude of #Cognalyzer® #psychoactive effects predictions and reported subjective drug effects for 4 h post-#cannabis inhalation. Read the findings here: https://t.co/OXKXfm67w3 https://t.co/jFVOOqkGUJ

Nov 2, 2021 · 3 likes · 1 share · 958 followers View post →